Swiss National Bank
VTYX

Swiss National Bank’s Ventyx Biosciences VTYX Stock Holding History

Swiss National Bank’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-90,200
Closed -$223K – 2529
2023
Q4 		$223K Hold
90,200
– – ﹤0.01% 2531
2023
Q3 		$3.13M Buy
90,200
+7,800
+9% +$270K ﹤0.01% 1566
2023
Q2 		$2.7M Buy
82,400
+45,700
+125% +$1.58M ﹤0.01% 1693
2023
Q1 		$1.23M Sell
36,700
-4,200
-10% -$163K ﹤0.01% 2129
2022
Q4 		$1.34M Buy
+40,900
New +$1.21M ﹤0.01% 2159

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Swiss National Bank's VTYX Position: Q1 2024 in Review

Swiss National Bank sold out of Ventyx Biosciences (VTYX) in Q1 2024, closing a stake of 90,200 shares — an estimated $223K sold.

Swiss National Bank first reported a position in VTYX in Q4 2022 and held it in 5 quarters. The position peaked at $3.13M in Q3 2023. 126 funds tracked by Wall St. Rank hold VTYX as of Q1 2024.

  • Swiss National Bank reported no remaining Ventyx Biosciences position as of Q1 2024 after selling out during the quarter.
  • Swiss National Bank sold 90,200 Ventyx Biosciences shares in Q1 2024, an estimated $223K.
  • Swiss National Bank first reported a position in Ventyx Biosciences in Q4 2022 and held it in 5 quarters.
  • Swiss National Bank's Ventyx Biosciences position peaked at $3.13M in Q3 2023.
  • 126 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2024.

Based on Swiss National Bank's 13F filing for Q1 2024, filed 7 May 2024.